Apriem Advisors’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q4
Sell
-1,600
Closed -$8K 528
2014
Q3
$8K Buy
+1,600
New +$8K ﹤0.01% 397